Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Odesa Criteria 2026 (OC26) for the Diagnosis of Autoimmune Pancreatitis

NCT07536841 is registered in ClinicalTrials.gov with Military Medical Clinical Center of the Southern Region, Ukraine as lead sponsor.

NCT NCT07536841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07536841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Odesa Criteria 2026 (OC26) for the Diagnosis of Autoimmune Pancreatitis
Lead sponsor
Military Medical Clinical Center of the Southern Region, Ukraine
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2026
Completion date
December 1, 2026
Enrollment
82 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune pancreatitis, chronic pancreatitis, igg4-related diseases, pancreatic cancer